Registrato: 29/06/19 03:03
|Epidermal Growth Factor Receptor (EGFR) Antibodies Market 2016 Industry Size , Shares, Segment & Fore Business Articles | July 11, 2016
The report covers forecast and analysis for the epidermal growth factor receptor (EGFR) antibodies market on a global and regional level. EGFR is the primary receptor recognized in a group of receptors and is a cell surface protein that binds to epidermal growth factor.
Epidermal Growth Factor Receptor (EGFR) Antibodies Market - Global Industry Perspective, Comprehensive Analysis and Forecast , 2015 Ė 2021
Free sample @
EGFR is the primary receptor recognized in a group of receptors and is a cell surface protein that binds to epidermal growth factor. EGFR is a cell membrane growth factor receptor characterized by tyrosine kinase receptor which plays very important role in the control of key cellular transduction pathways in both normal and cancerous cells. EGFR?is the first molecular target against which monoclonal?antibodies?(mAb) have been developed in cancer therapy.
On the basis of types, the global?epidermal growth factor receptor (EGFR) antibodies market is segmented into cetuximab, panitumumab, and nimotuzumab. Cetuximab and panitumumab are the most favored EGFR antibodies which are utilized for treatment of cancer. Nimotuzumab?is a humanized monoclonal antibody that recognizes the EGFR antibody. These antibodies are used in the treatment of colorectal tumor as single chairmen and in mix with routine chemotherapy.
The report covers forecast and analysis for the epidermal growth factor receptor (EGFR) antibodies market?on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million). The report also offers detailed competitive landscape of the global epidermal growth factor receptor (EGFR) antibodies market. It includes company market share analysis , product portfolio of the major industry participants. The report provides detailed segmentation of the epidermal growth factor receptor (EGFR) antibodies market based on type segment. Cetuximab, panitumumab, and nimotuzumab are different type of EGFR antibodies.
Increasing rate of cancer around the world, and advancement in the treatments are few drivers for EGFR antibody market. Prevalence of cancer is high in North America specifically in U.S. Cancer cases globally are escalating at an alarming rate. Cancer represents a key challenge to development , undermining economic and social advances all over the world. Breast cancer is most common diagnosed cancer and second leading cause of death amongst women in the U.S. According to World Cancer Report, produced by the WHO's specialized cancer agency, predicted that new cancer cases would rise from 14 million annually in 2012 to 22 million within two decades.
Read More @
Geographically, epidermal growth factor receptor (EGFR) antibodies market has been segmented into North America , Europe, Asia Pacific,?Latin America, and?Middle East?&?Africa. EGFR antibody market was dominated by North America followed by Europe. Key players in this market are Biocon ltd , Bristol-Myers Squibb, Vaccinex, NovelMed Therapeutics, Janssen Biotech (J&J) , Merck, Angiochem , Bio-Synthesis, Antibody Systems
3422 SW 15 Street ,Suit #8138
Deerfield Beach,Florida 33442
Toll Free: +1-855-465-4651 (USA-CANADA)
If you insist on your tenants having tenant insurance you may benefit from lower premiums on your landlord insurance policies. We all know that you have a duty to insure the building but this insurance cost can destroy your profits so it pays to try to reduce this expenditure if you can.
There are other ways to reduce the cost of insurance cover. Pick your tenants with care. Insurance companies like elderly tenants or those who are more likely to be at home during the day, such as housewives. This means that the property is likely to be occupied more often thus preventing burglaries and criminal damage. Installing extra security such as fire as well as burglar alarms will also help to push down cost.
If you avoid certain types of tenants considered to be high risk by the insurance companies, like , students and those on social welfare benefits, your insurance premiums are likely to be lower. Some landlords specialize in renting to these groups. If you fall into this category increasing the excess on your policy as well as having tenant insurance in place will help achieve lower premiums on your plan.
Donít over insure your building by design or accident. You donít usually insure a building for the current market value as the insurance company isnít interested in the value it would sell at. It is only interested in the amount it would cost to rebuild the building if it were to fall down or be badly damaged due to fire etc. So check the amount of cover you have in place to make sure you havenít overstated the amount you need and are paying needlessly high premiums for the privilege of making this mistake.
Having a lease that stipulates all tenants need tenant insurance is only one of many ways to reduce your insurance costs when you are a landlord.
Need help finding a renter insurance quote? Join us on the web at:
Will be slightly grilled tuna and pasta, artichoke hearts, green olives and tomatoes mixed with green olives accompanied by micro-roasted tuna will emit a unique seductive fragrance Road , Green olives called, have a high聽significant role in the maintenance of the nutritional value of the heart, while also serving as the thirst quencher of the seminiferous and detoxification.